Breaking News

Today Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
TSM TSMC $38.98 -0.03 (-0.08%) 07:26 02/22/19 02/22 07:26 02/22/19 07:26 Periodicals	TSMC getting traction for AI, 5G 'boom' with its EUV process, DigiTimes says » The upcoming Mobile World… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

Yesterday
MSFT Microsoft $109.25 2.05 (1.91%) , CBS CBS $50.70 -0.5 (-0.98%) 12:52 02/21/19 02/21 12:52 02/21/19 12:52 Hot Stocks	Showtime taps Otto Bathurst to direct 'Halo' show, announces nine episode order » CBS's (CBS) Showtime… CBS's (CBS) Showtime announced that Otto Bathurst, director of 2018 film "Robin Hood" and the first episode of the show "Black Mirror," is set to direct the Showtime series "Halo," based on the Xbox (MSFT) video game franchise with Kyle Killen serving as executive producer, writer and showrunner. Bathurst will helm multiple episodes and executive produce the live-action series, which has an initial nine-episode order. Produced by Showtime in partnership with 343 Industries, along with Steven Spielberg's Amblin Television, "Halo" will begin production later this year, the company said. MSFT Microsoft $109.25 2.05 (1.91%) CBS CBS $50.70 -0.5 (-0.98%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb 25 Feb 01 Mar 03 Mar 04 Mar 05 Mar 06 Mar 06 Mar 07 Mar 11 Mar 18 Mar
EA Electronic Arts $97.85 -0.78 (-0.79%) , SNE Sony $47.81 0.9003 (1.92%) … 12:47 02/21/19 02/21 12:47 02/21/19 12:47 On The Fly	Game On: Piper ups EA price target ahead of 'Anthem' launch » Shares of Electronic Arts… Open Full Text EA Electronic Arts $97.85 -0.78 (-0.79%) SNE Sony $47.81 0.9003 (1.92%) MSFT Microsoft $109.35 2.15 (2.01%) ATVI Activision Blizzard $42.65 -0.14 (-0.33%) UBSFY Ubisoft $0.00 (0.00%) TCEHY Tencent $0.00 (0.00%) DIS Disney $113.65 -0.04 (-0.04%) KKR KKR $23.52 -0.13 (-0.55%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 01 Mar 03 Mar 04 Mar 04 Mar 06 Mar 07 Mar 07 Mar 12 Mar 13 Mar 18 Mar
ATTU Attunity $23.49 3.59 (18.04%) , GOOGL Alphabet Class A $1,107.37 -13.23 (-1.18%) … 12:14 02/21/19 02/21 12:14 02/21/19 12:14 Recommendations	Attunity, Alphabet Class A, Alphabet, Amazon.com, Microsoft analyst commentary at Needham » Needham sees… Needham sees 'real' chance for competing offer for Attunity. After Attunity (ATTU) announced an agreement to be acquired by Qlik in a deal valued at $560M, or $23.50 per share in cash, Needham analyst Jack Andrews called the timing "somewhat surprising" and said he believes "the chance of a competing offer is real." Andrews, who believes Attunity would gain more leverage as part of either a public cloud vendor like Amazon Web Services (AMZN), Microsoft's (MSFT) Azure, or Google Cloud (GOOGL) or a larger technology firm that wants to further increase its presence in software, contends that the deal price represents a meaningful discount to its peers. He keeps a Buy rating and $31 price target on Attunity shares. ATTU Attunity $23.49 3.59 (18.04%) GOOGL Alphabet Class A $1,107.37 -13.23 (-1.18%) GOOG Alphabet $1,101.44 -12.47 (-1.12%) AMZN Amazon.com $1,614.64 -7.46 (-0.46%) MSFT Microsoft $109.18 1.98 (1.85%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 01 Mar 03 Mar 04 Mar 06 Mar 06 Mar 07 Mar 18 Mar
MSFT Microsoft $107.20 -0.56 (-0.52%) 09:16 02/21/19 02/21 09:16 02/21/19 09:16 Recommendations	Microsoft analyst commentary at Morgan Stanley » Microsoft shares present… Microsoft shares present 'best risk/reward in software,' says Morgan Stanley. Morgan Stanley analyst Keith Weiss said his review of new disclosures from recent results, SEC filings and conversations with the company have added to his confidence in his forecasts for Microsoft. He continues to believe that the company's recent quarter results were "strong where it matters" and he sees see the relative underperformance in the stock year-to-date as a buying opportunity. As the IT conversation shifts from pure Public Cloud towards Hybrid Cloud architectures, Weiss contends that Microsoft will pull "ahead as the best secularly positioned firm in tech" and he thinks the company's secular positioning and durable growth give it the "best risk/reward in software." Weiss maintains an Overweight rating and $140 price target on Microsoft shares. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 01 Mar 03 Mar 04 Mar 06 Mar 07 Mar 18 Mar

MSFT Microsoft $107.20 -0.56 (-0.52%) 08:20 02/21/19 02/21 08:20 02/21/19 08:20 Conference/Events	Credit Suisse security analysts to hold an analyst/industry conference call » Analysts, along with… Analysts, along with Microsoft's General Manager of Security Product Marketing, Andrew Conway, participate in the Disruptive Security Series Analyst/Industry conference call to be held on March 1 at 2 pm. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 01 Mar 03 Mar 04 Mar 06 Mar 07 Mar 18 Mar
KO Coca-Cola $45.12 0.3 (0.67%) , ZNGA Zynga $5.04 -0.06 (-1.18%) … 07:30 02/21/19 02/21 07:30 02/21/19 07:30 Options	Unusual put flow in option market yesterday » Notable put activity was… Notable put activity was cited Wednesday in Coca Cola (KO), Zynga (ZNGA), Applied Optoelectronics (AAOI), Taiwan Semi (TSM), Fifth Third (FITB), Hormel Foods (HRL), and Quanta Services (PWR). KO Coca-Cola $45.12 0.3 (0.67%) ZNGA Zynga $5.04 -0.06 (-1.18%) AAOI Applied Optoelectronics $14.62 -0.305 (-2.04%) TSM TSMC $39.01 0.54 (1.40%) FITB Fifth Third $27.92 0.405 (1.47%) HRL Hormel Foods $43.13 -0.18 (-0.42%) PWR Quanta Services $36.60 0.925 (2.59%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb 21 Feb 21 Feb 21 Feb 25 Feb 26 Feb 27 Feb 28 Feb 28 Feb 03 Mar 11 Mar

Wednesday
TSM TSMC $39.24 0.77 (2.00%) 12:40 02/20/19 02/20 12:40 02/20/19 12:40 Options	Taiwan Semi sees opening put buying » Taiwan Semi sees opening… Taiwan Semi sees opening put buying. Shares up 80c to $39.25 and Apr 39s trade $1.15 to 1.20. More than 6K changed hands against 71 open interest and defensive positions are being opened after the company reported updated guidance last week: on 2/15, the company said January revenues fell 2.1% and that an incident involving abnormally treated photoresist materials would negatively impact Q1 results. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
EA Electronic Arts $99.25 -3.73 (-3.62%) , ATVI Activision Blizzard $43.82 -0.66 (-1.48%) … 12:35 02/20/19 02/20 12:35 02/20/19 12:35 On The Fly	Game On: An exclusive talk with Beamdog CEO Trent Oster » 'NEVERWINTER NIGHTS'… Open Full Text EA Electronic Arts $99.25 -3.73 (-3.62%) ATVI Activision Blizzard $43.82 -0.66 (-1.48%) TTWO Take-Two $89.77 -3.52 (-3.77%) NTDOY Nintendo $0.00 (0.00%) MSFT Microsoft $106.99 -0.77 (-0.71%) SNE Sony $46.86 0.65 (1.41%) TCEHY Tencent $0.00 (0.00%) UBSFY Ubisoft $0.00 (0.00%) CCOEY Capcom $0.00 (0.00%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	01 Mar 03 Mar 06 Mar 07 Mar 12 Mar 13 Mar 18 Mar
PRQR ProQR Therapeutics $12.52 -1.475 (-10.54%) 07:10 02/20/19 02/20 07:10 02/20/19 07:10 Recommendations	ProQR Therapeutics analyst commentary at Citi » Citi opens 90-day… Citi opens 90-day catalyst watch on ProQR Therapeutics. Citi analyst Yigal Nochomovitz opened a 90-day catalyst watch on ProQR Therapeutics in anticipation of the interim Phase 1/2 Wings data for QR-313 in dystrophic epidermolysis bullosa. On positive data, or evidence of exon skipping in biopsies and evidence of skin lesion/blister resolution, the analyst sees the stock up 15%-25%. On negative data, he sees downside of 10%-15%. Nochomovitz has a Buy rating on ProQR Therapeutics. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

On The Fly

News and insights, exclusive to thefly.com

08:44	Planet Fitness a platform like Amazon, not a gym, Jefferies says in upgrade»
20:25	Notable companies reporting before tomorrow's open»
19:05	Fly Intel: After Hours Movers»
12:54	Notable companies reporting before tomorrow's open»
12:45	Notable companies reporting after market close»

View all On The Fly Stories »

Upcoming
Events (10)

RY	Royal Bank of Canada - RY
BBX	BBX Capital - BBX
	18th Annual Korea Conference
	10th Annual Capital Link Greek Shipping Forum
	Transplantation & Cellular Therapy Meetings of ASBMT & CIBMTR
	2019 Agricultural Outlook Forum
NWL ...	CAGNY Conference 2019
AIMT ...	AAAAI Annual Meeting 2019
	IASLC 2019 Targeted Therapies of Lung Cancer Meeting
JPM ...	U.S. Monetary Policy Forum

View all of today’s events »

Today’s
Syndicate (3)

ACAM	IPO
ADIL	Spot Secondary
TRIL	Spot Secondary

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial